- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Stellate Cell.
Displaying page 1 of 1.
EudraCT Number: 2019-001806-40 | Sponsor Protocol Number: STATLiver2019 | Start Date*: 2019-09-03 | |||||||||||
Sponsor Name:Afsnit 360, Gastroenheden | |||||||||||||
Full Title: Statins for prevention of disease progression and hospitalization in Liver Cirrhosis: A multi-center, randomized, double blind, placebo-controlled trial. The STATLiver Trial. | |||||||||||||
Medical condition: Cirrhosis of the liver | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004419-24 | Sponsor Protocol Number: RHMMED0687 | Start Date*: 2007-03-16 | |||||||||||
Sponsor Name:Southampton University Hospitals Trust (R&D) | |||||||||||||
Full Title: The Use of Sulfasalazine as an Anti-fibrotic in Acute Alcoholic Hepatitis | |||||||||||||
Medical condition: Acute Alcoholic Hepatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006221-77 | Sponsor Protocol Number: CRO 768 | Start Date*: 2007-06-26 | |||||||||||||||||||||
Sponsor Name:Clinical Research office, Faculty of Medicine, Imperial College London | |||||||||||||||||||||||
Full Title: Warfarin Anticoagualtion for liver fibrosis in patients transplanted for hepatitis C virus infection. | |||||||||||||||||||||||
Medical condition: Liver fibrosis in patients infected with hepatitis C virus after liver transplantation. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-003592-19 | Sponsor Protocol Number: NEOPAX-001 | Start Date*: 2012-12-11 |
Sponsor Name:CUB Erasme Hospital | ||
Full Title: Evaluation of tumoral perfusion modification by dynamic imaging after chemotherapy combining gemcitabine and nab-paclitaxel (Abraxane) in patients with potentially operable, locally advanced or met... | ||
Medical condition: Resectable (cohort 1) and locally advanced or metastatic (cohort 2) pancreatic ductal adenocarcinoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001979-70 | Sponsor Protocol Number: IVA_01_337_HNAS_16_002 | Start Date*: 2017-01-23 | |||||||||||
Sponsor Name:Inventiva S.A. | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, multicenter, dose-range, proof-of-concept, 24-week treatment study of IVA337 in adult subjects with nonalcoholic steatohepatitis (NASH) | |||||||||||||
Medical condition: Nonalcoholic steatohepatitis (NASH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) CZ (Completed) AT (Completed) PT (Completed) ES (Completed) NL (Completed) PL (Completed) FR (Completed) BG (Completed) SI (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.